Ocuphire Pharma Price on August 14, 2024
OCUPDelisted Stock | USD 1.13 0.06 5.04% |
If you're considering investing in Ocuphire Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ocuphire Pharma stands at 1.13, as last reported on the 23rd of November, with the highest price reaching 1.20 and the lowest price hitting 1.10 during the day. Ocuphire Pharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0551, which implies the firm had a -0.0551% return per unit of risk over the last 3 months. Ocuphire Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ocuphire Pharma's Coefficient Of Variation of (595.44), risk adjusted performance of (0.12), and Variance of 19.94 to confirm the risk estimate we provide.
Ocuphire Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ocuphire |
Sharpe Ratio = -0.0551
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | OCUP |
Estimated Market Risk
3.63 actual daily | 32 68% of assets are more volatile |
Expected Return
-0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ocuphire Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocuphire Pharma by adding Ocuphire Pharma to a well-diversified portfolio.
Related Headline
Protalix Biotherapeutics Headline on 14th of August 2024
Protalix Q2 Earnings Snapshot by finance.yahoo.com
HACKENSACK, N.J. Protalix BioTherapeutics Inc. PLX on Wednesday reported a loss of 2.2 million in its second quarter. The Hackensack, New Jersey-based company said it had a loss of 3 cents per share.
Ocuphire Pharma Valuation on August 14, 2024
It is possible to determine the worth of Ocuphire Pharma on a given historical date. On August 14, 2024 Ocuphire was worth 1.32 at the beginning of the trading date compared to the closed value of 1.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ocuphire Pharma stock. Still, in general, we apply an absolute valuation method to find Ocuphire Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ocuphire Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ocuphire Pharma's related companies.
Open | High | Low | Close | Volume | |
1.60 | 1.61 | 1.27 | 1.31 | 729,275 | |
08/14/2024 | 1.32 | 1.39 | 1.25 | 1.25 | 322,280 |
1.22 | 1.28 | 1.16 | 1.24 | 520,829 |
Backtest Ocuphire Pharma | | | Ocuphire Pharma History | | | Ocuphire Pharma Valuation | Previous | Next |
Ocuphire Pharma Trading Date Momentum on August 14, 2024
On August 15 2024 Ocuphire Pharma was traded for 1.24 at the closing time. The top price for the day was 1.28 and the lowest listed price was 1.16 . The trading volume for the day was 520.8 K. The trading history from August 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.80% . The trading delta at closing time against the current closing price is 4.80% . |
Ocuphire Pharma Fundamentals Correlations and Trends
By evaluating Ocuphire Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ocuphire Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ocuphire financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ocuphire Pharma Stock history
Ocuphire Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ocuphire is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ocuphire Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ocuphire Pharma stock prices may prove useful in developing a viable investing in Ocuphire Pharma
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan. Ocuphire Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people.
Ocuphire Pharma Stock Technical Analysis
Ocuphire Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Ocuphire Pharma Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Ocuphire Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ocuphire Pharma November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Ocuphire Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocuphire Pharma shares will generate the highest return on investment. By undertsting and applying Ocuphire Pharma stock market strength indicators, traders can identify Ocuphire Pharma entry and exit signals to maximize returns
Ocuphire Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ocuphire Pharma's price direction in advance. Along with the technical and fundamental analysis of Ocuphire Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ocuphire to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.12) | |||
Jensen Alpha | (0.74) | |||
Total Risk Alpha | (1.46) | |||
Treynor Ratio | 5.87 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Ocuphire Stock
If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |